MeiraGTx Holdings (MGTX) Net Cash Flow (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Net Cash Flow of $50.8 million for Q4 2025, up 351.01% on a YoY basis from $11.3 million in Q4 2024, and up 492.32% quarter-over-quarter from -$13.0 million in Q3 2025.
MeiraGTx Holdings (MGTX) Net Cash Flow (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Net Cash Flow for 9 years, with the latest figure at $50.8 million in Q4 2025.
- For the quarter ending Q4 2025, Net Cash Flow rose 351.01% year-over-year to $50.8 million; the trailing twelve-month figure through Dec 2025 stood at -$38.2 million (down 44.38% YoY), and the FY2025 full-year result was -$38.2 million, down 44.38% from the prior year.
- Net Cash Flow for Q4 2025 stood at $50.8 million, up from -$13.0 million in the prior quarter.
- The five-year high for Net Cash Flow was $64.3 million in Q4 2023, with the low at -$47.2 million in Q1 2023.
- Historically, Net Cash Flow has averaged -$7.3 million across 5 years, with a median of -$16.1 million in 2024.
- Annual changes were most pronounced in 2023 — Net Cash Flow surged 86848.65% — and 2025, when it tumbled 245.09%.
- MeiraGTx Holdings' Net Cash Flow stood at -$5.2 million in 2021, then surged by 101.41% to $74000.0 in 2022, then surged by 86848.65% to $64.3 million in 2023, then tumbled by 131.47% to -$20.2 million in 2024, then soared by 351.01% to $50.8 million in 2025.
- The last three Net Cash Flow figures came in at $50.8 million (Q4 2025), -$13.0 million (Q3 2025), and -$39.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 50.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 50.83 Mn |
| Dec 31, 2025 | 50.83 Mn |
| Sep 30, 2025 | -12.96 Mn |
| Sep 30, 2025 | -12.96 Mn |
| Jun 30, 2025 | -39.28 Mn |
| Jun 30, 2025 | -39.28 Mn |
| Mar 31, 2025 | -36.83 Mn |
| Mar 31, 2025 | -36.83 Mn |
| Dec 31, 2024 | -20.25 Mn |
| Dec 31, 2024 | -20.25 Mn |
| Sep 30, 2024 | 23.62 Mn |
| Sep 30, 2024 | 23.62 Mn |
| Jun 30, 2024 | -19.18 Mn |
| Jun 30, 2024 | -19.18 Mn |
| Mar 31, 2024 | -10.67 Mn |
| Mar 31, 2024 | -10.67 Mn |
| Dec 31, 2023 | 64.34 Mn |
| Dec 31, 2023 | 64.34 Mn |
| Sep 30, 2023 | -28.38 Mn |
| Sep 30, 2023 | -28.38 Mn |